MetaVia Inc. Common Stock
Symbol: MTVA (NASDAQ)
0.68
▼ (-0.56%) -0.004
Company Description:
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). DA-1726 is a novel oxyntomodulin (OXM) analogue functioning as a GLP-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist for the treatment of obesity that is designed to be administered once weekly subcutaneously.
Key Stats
- Today's Open: $0.667
- Today's High: $0.675
- Today's Low: $0.664
- Today's Volume: 2.66K
- Yesterday Close: $0.6788
- Yesterday High: $0.6851
- Yesterday Low: $0.6606
- Yesterday Volume: 44.15K
- Last Min Volume: 125
- Last Min High: $0.675
- Last Min Low: $0.675
- Last Min VWAP: $0.675
Company Profile
- Name: MetaVia Inc. Common Stock
- Website: https://www.metaviatx.com
- Listed Date: 2016-08-04
- Location: CAMBRIDGE, MA
- Market Status: Active
- CIK Number: 0001638287
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $16.43M
- Round Lot: 100
- Outstanding Shares: 24.20M
- Asset Type: CS
RECENT FILINGS FOR MTVA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-13 | 4 | View |
| 2025-08-07 | 8-K | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-08-06 | 8-K | View |
| 2025-08-04 | 8-K | View |
| 2025-07-10 | EFFECT | View |
| 2025-07-10 | 424B3 | View |
| 2025-07-09 | 8-K | View |
| 2025-07-08 | CORRESP | View |
| 2025-07-08 | UPLOAD | View |
| 2025-07-02 | S-3 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-06-30 | 8-K | View |
Latest News on MTVA